Image
06.11.2024
Lab to Life: Targeting structural proteins to prevent type 2 diabetes
We’re bringing the exciting research that we’re funding from the Lab to Life in our new series.
customer support
customer support
We take a look at some of the exciting diabetes research developments announced in July, including how teplizumab targets type 1 diabetes and understanding the risk of eating disorders for people taking part in type 2 diabetes remission programmes.
Read more